Colchicine may be of therapeutic benefit in prurigo pigmentosa

Basit Öğe Kaydı
dc.contributor.authorAn, Isa
dc.contributor.authorUcmak, Derya
dc.contributor.authorIbiloglu, Ibrahim
dc.contributor.authorDemir, Vasfiye
dc.contributor.authorAkdeniz, Sedat
dc.date.accessioned2024-04-24T17:11:48Z
dc.date.available2024-04-24T17:11:48Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.description.abstractPrurigo pigmentosa (PP) is a rare inflammatory skin disease. Neutrophil-mediated inflammation is considered to be responsible for the etiopathogenesis of PP. We consider that colchicine may be an effective agent in the treatment of PP since it exerts an antiinflammatory effect by inhibiting neutrophil chemotaxis. Further studies are required to verify whether colchicine is an effective treatment option for PP.en_US
dc.identifier.doi10.1111/pde.13480
dc.identifier.endpageE203en_US
dc.identifier.issn0736-8046
dc.identifier.issn1525-1470
dc.identifier.issue3en_US
dc.identifier.pmid29644750
dc.identifier.scopus2-s2.0-85046744316
dc.identifier.scopusqualityQ2
dc.identifier.startpageE202en_US
dc.identifier.urihttps://doi.org/10.1111/pde.13480
dc.identifier.urihttps://hdl.handle.net/11468/17731
dc.identifier.volume35en_US
dc.identifier.wosWOS:000432027900021
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Dermatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPharmacologyen_US
dc.subjectPruritusen_US
dc.subjectTherapysystemicen_US
dc.titleColchicine may be of therapeutic benefit in prurigo pigmentosaen_US
dc.titleColchicine may be of therapeutic benefit in prurigo pigmentosa
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu